The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Understanding the Roles of FAK in Cancer: Inhibitors, Genetic Models, and New Insights
Open accessAbstract
Focal adhesion kinase (FAK) is a protein tyrosine kinase that regulates cellular adhesion, motility, proliferation and survival in various types of cells. Interestingly, FAK is activated and/or overexpressed in advanced cancers, and promotes cancer progression and metastasis. For this reason, FAK became a potential therapeutic target in cancer, and small molecule FAK inhibitors have been developed and are being tested in clinical phase trials. These inhibitors have demonstrated to be effective by inducing tumor cell apoptosis in addition to reducing metastasis and angiogenesis. Furthermore, several genetic FAK mouse models have made advancements in understanding the specific role of FAK both in tumors and in the tumor environment. In this review, we discuss FAK inhibitors as well as genetic mouse models to provide mechanistic insights into FAK signaling and its potential in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FAK in cancer: mechanistic findings and clinical applications
Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3792 · Cited by 1,381
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
Tavora, B., Reynolds, L. E., Batista, S., Demircioglu, F., Fernandez, I., Lechertier, T., Lees, D. M., Wong, P.-P., Alexopoulou, A., Elia, G., et al. (2014) · Nature · doi:10.1038/nature13541 · Cited by 163 · cited 1×
“Surprisingly, endothelial cell FAK knockout sensitized the tumors to chemotherapy (Tavora et al. 2014), suggesting that EC FAK may play a novel role in protecting tumors from chemotherapy, and that targeting EC FAK may enhance current cancer therapeutics.”
BackgroundBarsukov, I. L., Prescot, A., Bate, N., Patel, B., Floyd, D. N., Bhanji, N., Bagshaw, C. R., Letinic, K., Di Paolo, G., De Camilli, P., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303850200 · Cited by 95
Research works printed but not linked: 124
- 10.1038/sj.onc.1202957 · DOI · Paper page
- 10.1073/pnas.0530291100 · DOI · Paper page
- 10.1016/j.ccr.2010.10.023 · DOI · Paper page
- 10.1038/ncb829 · DOI · Paper page
- 10.1016/S0898-6568(99)00076-5 · DOI · Paper page
- 10.1158/1078-0432.CCR-07-1511 · DOI
- 10.1038/nm0797-730 · DOI · Paper page
- Bottsford-Miller J, Sanguino A., Duangmani Thanapprapasr D., Pecot C.V., Stone R.L., Auger K., Nick A.M., Sood A.K. (2011) Enhancing anti-angiogenic therapy by blocking focal adhesion kinase In Cancer Res. 230 · doi:10.1158/1538-7445.am2011-lb-230
- 10.1002/embj.201386399 · DOI
- 10.1083/jcb.200506184 · DOI · Paper page
- 10.1128/MCB.15.2.954 · DOI · Paper page
- 10.1126/stke.120pe22 · DOI
- Cance WG, 2000, Clin Cancer Res, 6, 2417
- Cance WG, 2000, Clin Cancer Res, 6, 2417
- 10.1158/1078-0432.CCR-05-1583 · DOI
- Cary LA, 1996, J Cell Sci, 108, 1787, 10.1242/jcs.109.7.1787 · DOI · Paper page
- 10.1074/jbc.M509188200 · DOI
- 10.1074/jbc.274.38.26901 · DOI
- 10.1016/j.devcel.2011.11.002 · DOI · Paper page
- 10.1002/pro.542 · DOI
- 10.1074/jbc.M110.122549 · DOI
- 10.1002/ijc.27745 · DOI
- 10.1016/j.yexcr.2007.09.005 · DOI · Paper page
- 10.1128/MCB.23.22.8030-8041.2003 · DOI · Paper page
- 10.1074/jbc.M109.067280 · DOI
- 10.1186/1471-2164-7-198 · DOI
- 10.1016/j.bbrc.2013.11.134 · DOI
- 10.1038/nature08908 · DOI · Paper page
- 10.1038/nrm2996 · DOI · Paper page
- 10.1083/jcb.134.3.793 · DOI · Paper page
- 10.1007/s00268-005-0165-z · DOI
- Golubovskaya VM, 2012, Carcinogenesis, 33, 1004, 10.1093/carcin/bgs120 · DOI
- 10.1074/jbc.M414172200 · DOI · Paper page
- 10.1021/jm800483v · DOI · Paper page
- 10.1186/1471-2407-9-280 · DOI
- 10.1073/pnas.92.8.3439 · DOI · Paper page
- 10.1016/j.cell.2012.02.008 · DOI · Paper page
- 10.1158/0008-5472.CAN-07-2667 · DOI · Paper page
- Haskell H, 2003, Clin Cancer Res, 9, 2157
- 10.1074/jbc.C100760200 · DOI
- 10.1080/15216540211470 · DOI · Paper page
- He ZX, 2006, Sichuan Da Xue Xue Bao Yi Xue Ban, 37, 876
- 10.1074/jbc.M111.322883 · DOI
- 10.4161/cc.8.15.9145 · DOI · Paper page
- 10.1016/S0065-2776(08)60582-9 · DOI · Paper page
- 10.1038/377539a0 · DOI · Paper page
- 10.1200/JCO.2011.38.9346 · DOI · Paper page
- 10.1083/jcb.201307067 · DOI · Paper page
- 10.1016/j.bbrc.2012.08.129 · doi:10.1016/j.bbrc.2012.08.129
- 10.1002/pros.10215 · DOI · Paper page
- 10.1073/pnas.0710091104 · DOI · Paper page
- 10.1038/modpathol.3800424 · DOI · Paper page
- 10.1002/path.3018 · DOI · Paper page
- 10.1038/376737a0 · DOI · Paper page
- 10.1158/0008-5472.CAN-06-2030 · DOI · Paper page
- 10.1007/978-1-59745-280-9_10 · DOI · Paper page
- 10.1083/jcb.201105103 · DOI
- 10.1016/j.cell.2007.05.041 · DOI · Paper page
- 10.4161/cc.6367 · DOI
- 10.1007/s10059-013-0139-1 · DOI
- 10.1016/j.molcel.2007.11.031 · DOI · Paper page
- 10.1074/jbc.M110.129999 · DOI
- 10.1083/jcb.201109067 · DOI
- 10.1517/14728220903473194 · DOI
- Liu A, 2013, Chin J Cancer, 32, 483
- 10.1158/1535-7163.MCT-06-0476 · DOI · Paper page
- 10.1158/0008-5472.CAN-08-3078 · DOI · Paper page
- 10.1158/0008-5472.CAN-13-1351 · DOI
- 10.1038/emboj.2009.178 · DOI
- 10.1038/emboj.2009.178 · DOI
- 10.1101/gad.316304 · DOI · Paper page
- 10.1101/gad.316304 · DOI · Paper page
- 10.1038/nrm1549 · DOI · Paper page
- 10.1016/j.ceb.2006.08.011 · DOI · Paper page
- 10.1038/sj.bjc.6601050 · DOI · Paper page
- 10.1074/jbc.M705403200 · DOI
- 10.1002/cncr.26382 · doi:10.1002/cncr.26382
- 10.2741/1239 · DOI
- 10.1128/MCB.19.7.4806 · DOI · Paper page
- 10.1016/j.humpath.2010.06.004 · DOI
- 10.1242/jcs.00373 · DOI · Paper page
- 10.3389/fendo.2012.00125 · DOI
- 10.1038/sj.onc.1209327 · DOI · Paper page
- 10.2174/138920311795659452 · doi:10.2174/138920311795659452
- 10.2353/ajpath.2008.080308 · DOI
- 10.1158/0008-5472.CAN-07-5155 · DOI · Paper page
- 10.1093/jb/mvs144 · DOI
- 10.1128/MCB.14.3.1680 · DOI · Paper page
- 10.1128/MCB.18.5.2571 · DOI · Paper page
- 10.1152/ajplung.00094.2013 · DOI
- 10.1002/ijc.26351 · DOI
- 10.1126/scitranslmed.3008639 · DOI · Paper page
- 10.1083/jcb.200411155 · DOI · Paper page
- 10.1002/mc.20297 · DOI · Paper page
- 10.1073/pnas.0904227106 · DOI · Paper page
- 10.1038/35010517 · DOI · Paper page
- 10.1093/emboj/17.20.5933 · DOI · Paper page
- Singh SK, 2003, Cancer Res, 63, 5821
- 10.1158/1535-7163.MCT-09-0262 · DOI
- 10.1074/jbc.M606695200 · DOI · Paper page
- 10.1016/S0002-9440(10)63370-6 · DOI · Paper page
- 10.1038/labinvest.3780211 · DOI
- 10.1158/1535-7163.MCT-11-0261 · DOI · Paper page
- 10.4161/cbt.28882 · DOI
- 10.1158/1535-7163.MCT-13-1063 · DOI
- 10.4161/cbt.9.10.11434 · DOI · Paper page
- 10.1002/emmm.201000106 · DOI
- 10.1016/S0748-7983(03)00120-3 · doi:10.1016/s0748-7983(03)00120-3
- 10.1038/bjc.2014.219 · doi:10.1038/bjc.2014.219
- 10.4161/cbt.9.10.11433 · DOI
- Wang XY, 2005, Ai Zheng, 24, 1091
- 10.2174/15680096113136660102 · DOI · Paper page
- 10.1016/0140-6736(93)92881-S · DOI · Paper page
- 10.1083/jcb.200710038 · DOI · Paper page
- 10.1038/onc.2012.230 · DOI
- 10.1016/j.devcel.2005.06.006 · DOI · Paper page
- Xu LH, 1996, Cell Growth Diff, 7, 413
- 10.1074/jbc.M910027199 · DOI · Paper page
- Xu LH, 1998, Cell Growth Differ, 9, 999
- 10.1007/s10549-010-1150-2 · doi:10.1007/s10549-010-1150-2
- 10.1016/S1357-2725(97)00008-3 · DOI
- 10.1007/s10555-008-9165-4 · DOI · Paper page
- 10.1083/jcb.200912094 · DOI
- 10.4066/AMJ.2012.1006 · doi:10.4066/amj.2012.1006
Cited by
Gonzalez-Avila, G., Sommer, B., Mendoza-Posada, D. A., Ramos, C., Garcia-Hernandez, A. A., & Falfan-Valencia, R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.02.010 · Cited by 373
The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review
Zhou, J., Yi, Q., & Tang, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1265-1 · Cited by 287
Focal adhesion kinase: from biological functions to therapeutic strategies
Tan, X., Yan, Y., Song, B., Zhu, S., Mei, Q., & Wu, K. (2023) · Experimental Hematology & Oncology · doi:10.1186/s40164-023-00446-7 · Cited by 158
The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer
Tiede, S., Meyer-Schaller, N., Kalathur, R. K. R., Ivanek, R., Fagiani, E., Schmassmann, P., Stillhard, P., Häfliger, S., Kraut, N., Schweifer, N., et al. (2018) · Oncogenesis · doi:10.1038/s41389-018-0083-1 · Cited by 66
Yoshimura, A., Horinaka, M., Yaoi, T., Ono, H., Itoh, K., Yamada, T., Takayama, K., & Sakai, T. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02727-2 · Cited by 15
Metadata
- Authors
- Yoon, H., Dehart, J. P., Murphy, J. M., & Lim, S.-T. S.
- Venue
- Journal of Histochemistry & Cytochemistry
- Publisher
- SAGE Publications
- Published
- 2014-11-07
- Volume
- 63
- Issue
- 2
- Pages
- 114-128
- ISSN
- 0022-1554 (ISSN-L)
- 1551-5044
- OpenAlex
- W1970304603
- Cited by
- 218
- References
- 3
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding the Roles of FAK in Cancer: Inhibitors, Genetic Models, and New Insights. https://app.cochat.ai/papers/10.1369/0022155414561498
- The paper
- Yoon, H., Dehart, J. P., Murphy, J. M., & Lim, S.-T. S. (2015). Understanding the Roles of FAK in Cancer: Inhibitors, Genetic Models, and New Insights. Journal of Histochemistry & Cytochemistry. https://doi.org/10.1369/0022155414561498
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.